FDA approves pediatric dose of Abbott's enzyme drug Creon - Related Stories - AAP SmartBrief
Links shared publicly online about this topic.
- 216total visits
FDA approves pediatric dose of Abbott's enzyme drug Creon - Related Stories - AAP SmartBrief
The FDA approved a 3,000-unit lipase capsule of Abbott Laboratories' Creon to treat exocrine pancreatic insufficiency in infants with cystic fibrosis. "This approval means that Creon will now be available in four dosing options, including both the lowest and highest dosage strengths available to pa…
View full resource at smartbrief.com
Tags: Pancreatic Disease, Cystic Fibrosis, Drug, Children's Health, FDA, American Academy of Pediatrics
Most Recently Shared on June 15, 2011 at 11:09 pm By:
FDA approves pediatric dose of Abbott's enzyme drug Creon http://t.co/FtGNnCf
Advertisement
